Evidence map›Paper›PMID 37225405›Full record

Observational studyJournal of neurology, neurosurgery, and psychiatry2023

Early autoimmunity and outcome in virus encephalitis: a retrospective study based on tissue-based assay.

Ding Liu, Pei-Hao Lin, Hui-Lu Li, Jie Yang, Yong You, Xiao Yang, Li-Hong Jiang, Cai-Yu Ma, Lu-Fen Xu, Qing-Xia Zhang and 32 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Journal of neurology, neurosurgery, and psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. EBV-associated autoimmune glial fibrillary acidic protein astrocytopathy with lumbosacral leptomeningeal enhancement: a case report and literature review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors at 20 institutions in 1 country.

Ding LiuDepartment of Neurology, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and The Ministry of Education of China, Institute of Neuroscience, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Pei-Hao LinDepartment of Neurology, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and The Ministry of Education of China, Institute of Neuroscience, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.ORCID 0000-0002-0775-795X
Hui-Lu LiDepartment of Neurology, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and The Ministry of Education of China, Institute of Neuroscience, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Jie YangDepartment of Neurology, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and The Ministry of Education of China, Institute of Neuroscience, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.ORCID 0000-0001-5524-8925
Yong YouDepartment of Neurology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
Xiao YangDepartment of Neurology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.ORCID 0000-0003-3065-7225
Li-Hong JiangDepartment of Neurology, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and The Ministry of Education of China, Institute of Neuroscience, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Cai-Yu MaDepartment of Neurology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
Lu-Fen XuDepartment of Neurology, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and The Ministry of Education of China, Institute of Neuroscience, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Qing-Xia ZhangDepartment of Neurology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
Sha LiaoDepartment of Neurology, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and The Ministry of Education of China, Institute of Neuroscience, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Han ChenDepartment of Neurology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
Jia-Jia YueDepartment of Neurology, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and The Ministry of Education of China, Institute of Neuroscience, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Yu-Ying LuKey Laboratory of Microbial Molecular Biology of Hunan Province, Hunan Provincial Center for Disease Control and Prevention, Changsha, Hunan, China.
Chun LianDepartment of Neurology, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and The Ministry of Education of China, Institute of Neuroscience, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Yin LiuDepartment of Radiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.ORCID 0000-0003-3388-2575
Zhan-Hang WangDepartment of Neurology, Guangdong 999 Brain Hospital, Guangzhou, Guangdong, China.
Jin-Long YeDepartment of Neurology, Guangdong 999 Brain Hospital, Guangzhou, Guangdong, China.
Wei QiuDepartment of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Ya-Qing ShuDepartment of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Hai-Yang WangDepartment of Neurology, Jining No. 1 People's Hospital, Jining, China.
Hong-Li LiuDepartment of Neurology, First Hospital of Qinhuangdao, Qinhuangdao, Hebei, China.
Yue WangDepartment of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University, Chongqing, China.
Chun-Mei DuanDepartment of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University, Chongqing, China.
Huan YangDepartment of Neurology, Xiangya Hospital of Central South University, Changsha, Hunan, China.ORCID 0000-0003-1523-0338
Xiu-Ling WuDepartment of Neurology, Tangshan Gongren Hospital, Tangshan, Hebei, China.
Lu ZhangDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Hui-Yu FengDepartment of Neurology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Huan ChenDepartment of Neurology, Shantou Central Hospital, Shantou, Guangdong, China.
Hou-Shi ZhouDepartment of Neurology, Shantou Central Hospital, Shantou, Guangdong, China.
Qian-Hui XuDepartment of Neurology, Shenzhen People's Hospital, The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, China.ORCID 0000-0001-9677-2897
Gui-Xian ZhaoDepartment of Neurology, Huashan Hospital of Fudan University, Shanghai, China.
Teng-Fei OuDepartment of Neurology, The Second People's Hospital of Foshan, Foshan, Guangdong, China.
Jin-Liang WangDepartment of Neurology, The Second People's Hospital of Foshan, Foshan, Guangdong, China.
Yu-Hua LuDepartment of Neurology, People's Hospital of Chongqing Banan District, Chongqing, China.
Zhi-Feng MaoNeurimmunology Group, Institution of Kingmed, Guangzhou Medical University, Guangzhou, Guangdong, China.
Cong GaoDepartment of Neurology, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and The Ministry of Education of China, Institute of Neuroscience, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Jun GuoDepartment of Neurology, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.ORCID 0000-0001-8053-881X
Hong-Ya ZhangDepartment of Neurology, Shenzhen University General Hospital, Shenzhen, Guangdong, China.
Sheng ChenDepartment of Neurology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0001-7428-7153
Jing LiDepartment of Neurology, Xiangya Hospital of Central South University, Changsha, Hunan, China youminglong@126.com lijing.neurology@aliyun.com.
You-Ming LongDepartment of Neurology, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and The Ministry of Education of China, Institute of Neuroscience, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China youminglong@126.com lijing.neurology@aliyun.com.ORCID 0000-0002-4004-2948
Second Affiliated Hospital of Guangzhou Medical University · CNCentral South University · CNSun Yat-sen University · CNArmy Medical University · CNFoshan Second People's Hospital · CNGuangdong 999 Brain Hospital · CNHunan Provincial Center for Disease Control and Prevention · CNAir Force Medical University · CNFirst Affiliated Hospital of Zhengzhou University · CNFirst Hospital of Qinhuangdao · CNFudan University · CNHainan Medical University · CNJinan University · CNJining First People's Hospital · CNKingmed Diagnostics · CNNingxia Medical University · CNRuijin Hospital · CNShantou Central Hospital · CNShenzhen University · CNTangshan Gongren Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To explore the autoimmune response and outcome in the central nervous system (CNS) at the onset of viral infection and correlation between autoantibodies and viruses.

methodsA retrospective observational study was conducted in 121 patients (2016-2021) with a CNS viral infection confirmed via cerebrospinal fluid (CSF) next-generation sequencing (cohort A). Their clinical information was analysed and CSF samples were screened for autoantibodies against monkey cerebellum by tissue-based assay. In situ hybridisation was used to detect Epstein-Barr virus (EBV) in brain tissue of 8 patients with glial fibrillar acidic protein (GFAP)-IgG and nasopharyngeal carcinoma tissue of 2 patients with GFAP-IgG as control (cohort B).

resultsAmong cohort A (male:female=79:42; median age: 42 (14-78) years old), 61 (50.4%) participants had detectable autoantibodies in CSF. Compared with other viruses, EBV increased the odds of having GFAP-IgG (OR 18.22, 95% CI 6.54 to 50.77, p<0.001). In cohort B, EBV was found in the brain tissue from two of eight (25.0%) patients with GFAP-IgG. Autoantibody-positive patients had a higher CSF protein level (median: 1126.00 (281.00-5352.00) vs 700.00 (76.70-2899.00), p<0.001), lower CSF chloride level (mean: 119.80±6.24 vs 122.84±5.26, p=0.005), lower ratios of CSF-glucose/serum-glucose (median: 0.50[0.13-0.94] vs 0.60[0.26-1.23],

conclusionsAutoimmune responses are found at the onset of viral encephalitis. EBV in the CNS increases the risk for autoimmunity to GFAP.

Indexed as

EncephalitisEpstein-Barr Virus InfectionsAutoantibodiesAutoimmunityFemaleHerpesvirus 4, HumanHumansImmunoglobulin GMaleRetrospective StudiesAutoantibodiesImmunoglobulin Gautoimmune encephalitisclinical neurologyneuroimmunologyneurovirology

Identifiers

PMID37225405
PMCPMC10359542
OpenAlexW4377967665

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.